New Hope on the Horizon for Brain Cancer Patients The recent opening of the GIANT clinical trial in Australia offers new hope for thousands of Australians diagnosed with brain cancer every year.
This innovative treatment, developed by Professor Richard Scolyer and his team, targets glioblastoma, one of the most aggressive forms of brain cancer.
The trial's focus on immunotherapy represents a significant departure from traditional treatments that have barely changed over the past two decades.